Hepatocellular Carcinoma (HCC) Clinical Trials in Hangzhou, Zhejiang
10 recruitingHangzhou, Zhejiang, China
Showing 1–10 of 10 trials
Recruiting
Phase 2
A Prospective, Randomized Study of TACE Combined With Sintilimab, Bevacizumab, and Ipilimumab N01 Treating Advanced HCC
Hepatocellular Carcinoma (HCC)
Second Affiliated Hospital, School of Medicine, Zhejiang University36 enrolled1 locationNCT07422753
Recruiting
Phase 1Phase 2
A Clinical Study on the Safety, Tolerability and Efficacy of Neoantigen-based Personalized mRNA Therapy iNeo-Vac-R01 Plus PD-1 Inhibitor in Adjuvant Treatment of Liver Cancer Post Radical Resection
Hepatocellular Carcinoma (HCC)
Yinghua Xu20 enrolled1 locationNCT07495215
Recruiting
Phase 1
MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.
Unresectable Hepatocellular Carcinoma (HCC)Hepatoma
Suzhou Mednovo Yi Medical Technology Co., Ltd.40 enrolled8 locationsNCT07391839
Recruiting
Not Applicable
A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC)
Advanced Hepatocellular Carcinoma (HCC)
Zhejiang University12 enrolled2 locationsNCT07039201
Recruiting
Phase 2
ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression
Hepatocellular Carcinoma (HCC)
Abbisko Therapeutics Co, Ltd141 enrolled51 locationsNCT07327034
Recruiting
Phase 2
NWRD06 DNA Plasmid for HCC After Curative Resection.
Hepatocellular Carcinoma (HCC)
Newish Technology (Beijing) Co., Ltd.30 enrolled6 locationsNCT07324304
Recruiting
Phase 1Phase 2
Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma (HCC)
Zhejiang University20 enrolled1 locationNCT07123545
Recruiting
Phase 1Phase 2
Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Zhejiang Cancer Hospital10 enrolled2 locationsNCT06741020
Recruiting
Phase 1Phase 2
Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma (HCC)
Zhejiang University30 enrolled1 locationNCT06995105
Recruiting
Phase 1
A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma (HCC)
AbbVie20 enrolled11 locationsNCT06487559